Growth Metrics

Inogen (INGN) Common Equity (2016 - 2022)

Inogen has reported Common Equity over the past 11 years, most recently at $350.8 million for Q3 2022.

  • Quarterly results put Common Equity at $350.8 million for Q3 2022, down 10.25% from a year ago — trailing twelve months through Sep 2022 was $350.8 million (down 10.25% YoY), and the annual figure for FY2021 was $370.2 million, up 5.89%.
  • Common Equity for Q3 2022 was $350.8 million at Inogen, down from $356.5 million in the prior quarter.
  • Over the last five years, Common Equity for INGN hit a ceiling of $390.9 million in Q3 2021 and a floor of $246.3 million in Q1 2018.
  • Median Common Equity over the past 5 years was $349.6 million (2020), compared with a mean of $337.5 million.
  • Biggest five-year swings in Common Equity: soared 36.73% in 2018 and later fell 10.25% in 2022.
  • Inogen's Common Equity stood at $310.4 million in 2018, then increased by 11.02% to $344.6 million in 2019, then grew by 1.45% to $349.6 million in 2020, then increased by 5.89% to $370.2 million in 2021, then decreased by 5.24% to $350.8 million in 2022.
  • The last three reported values for Common Equity were $350.8 million (Q3 2022), $356.5 million (Q2 2022), and $358.3 million (Q1 2022) per Business Quant data.